Clinical Trials Logo
  1. Home
  2. Cutaneous Leishmaniases
  3. NCT03435419

Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan — CLeishPOCAFG  

Cutaneous Leishmaniases Clinical Trial

Official title:
Point of Care Tests for Cutaneous Leishmaniasis: Prospective Evaluation of LoopampTM and CL DetectTM Rapid Test for Cutaneous Leishmaniasis Diagnosis in Afghanistan

Clinical Trial Summary

New point-of-care (POC) tests are needed and assessing the performance of these tests for cutaneous leishmaniasis (CL) in Afghanistan may help increasing the number of CL patients with access to accurate diagnosis, and enable prompt treatment. Simpler tests could improve treatment access and benefit patients and communities, by reducing the risk of sequelae and the risk of disease transmission. CLeishPOCAFG aims to advance the diagnosis of CL by using more accurate and field-amenable methods.

Clinical Trial Description

The investigators enrolled 274 CL suspects in the study to determine the diagnostic performance of LoopampTM Leishmania Detection Kit and CL DetectTM Rapid Test for CL diagnosis in Afghanistan. The study was conducted at the National Malaria & Leishmaniasis Control Program (NMLCP) Leishmaniasis Clinic in Kabul, Afghanistan. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03435419
Study type Observational
Source Foundation for Innovative New Diagnostics, Switzerland
Contact
Status Completed
Phase N/A
Start date April 16, 2016
Completion date July 18, 2016
View Details
See also
  Status Clinical Trial Phase
Suspended NCT03292835 - Complex Cutaneous Leishmaniasis Healing Study in Algeria
Terminated NCT03208543 - Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan Phase 3
Completed NCT04512742 - A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies N/A
Completed NCT04004754 - Outcomes of Complicated CL in Ethiopia Treated With Miltefosine
Active, not recruiting NCT05332093 - Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
Active, not recruiting NCT04515186 - Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World Phase 3
Completed NCT02919605 - Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis Phase 2
Completed NCT03837431 - Cutaneous Leishmaniasis Diagnostic Study
Not yet recruiting NCT05493059 - Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study
Terminated NCT04001335 - Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium
Completed NCT03929016 - Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects Phase 1